This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Emmanuel Rossy: Innovator in Recombinant Polypeptide Therapeutics
Introduction
Emmanuel Rossy is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptide therapeutics. His innovative work focuses on engineered O-glycosylation, which has important implications for therapeutic applications.
Latest Patents
Emmanuel Rossy holds a patent titled "Engineered O-glycosylation in recombinant polypeptides and uses thereof." This invention relates to recombinant polypeptide therapeutics that feature an engineered O-linked amino acid glycosylation sequence. These polypeptides are covalently linked to O-glycans, allowing for the production of O-glycosylated polypeptides in mammalian cells. This process enables the presentation of both natural and unnatural O-glycan structures through metabolic labeling.
Career Highlights
Emmanuel Rossy is currently associated with Medimmune Limited, where he continues to advance his research in recombinant therapeutics. His work has the potential to enhance the efficacy of therapeutic proteins, making them more effective in treating various diseases.
Collaborations
Emmanuel collaborates with talented individuals in his field, including Adam Tibbles and Monika Anna Papworth. These collaborations foster innovation and contribute to the advancement of biotechnology.
Conclusion
Emmanuel Rossy is a pioneering inventor whose work in engineered O-glycosylation is shaping the future of recombinant polypeptide therapeutics. His contributions are vital to the ongoing development of effective treatments in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile